[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Multiple Sclerosis (MS) Drugs Sales Market Report 2017

November 2017 | 114 pages | ID: G873E8EA0FEEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Multiple Sclerosis (MS) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Multiple Sclerosis (MS) Drugs for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Multiple Sclerosis (MS) Drugs market competition by top manufacturers/players, with Multiple Sclerosis (MS) Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bayer AG
  • Bayhill Therapeutics
  • Biogen Idec
  • Cinnagen
  • Daiichi Sankyo
  • Eli Lilly
  • Fast Forward Llc
  • Antisense Therapeutics
  • Apitope
  • Five Prime Therapeutics
  • Genmab
  • Artielle Immunotherapeutics
  • Genzyme
  • Glaxosmithkline
  • Gw Pharmaceuticals
  • Innate Immunotherapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Copaxone (Glatiramer Acetate, Copolymer 1)
  • Novantrone (Mitoxantrone)
  • Gilenya (Fingolimod, Fty720)
  • Aubagio (Teriflunomide)
  • Tecfidera (Dimethyl Fumarate)
  • Firategrast (Sb683699, T-0047)
  • Siponimod (Baf312)
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • RRMS
  • SPMS
  • PPMS
  • PRMS
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Multiple Sclerosis (MS) Drugs Sales Market Report 2017

1 MULTIPLE SCLEROSIS (MS) DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Multiple Sclerosis (MS) Drugs
1.2 Classification of Multiple Sclerosis (MS) Drugs by Product Category
  1.2.1 Global Multiple Sclerosis (MS) Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Multiple Sclerosis (MS) Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Copaxone (Glatiramer Acetate, Copolymer 1)
  1.2.4 Novantrone (Mitoxantrone)
  1.2.5 Gilenya (Fingolimod, Fty720)
  1.2.6 Aubagio (Teriflunomide)
  1.2.7 Tecfidera (Dimethyl Fumarate)
  1.2.8 Firategrast (Sb683699, T-0047)
  1.2.9 Siponimod (Baf312)
  1.2.10 Others
1.3 Global Multiple Sclerosis (MS) Drugs Market by Application/End Users
  1.3.1 Global Multiple Sclerosis (MS) Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 RRMS
  1.3.3 SPMS
  1.3.4 PPMS
  1.3.5 PRMS
1.4 Global Multiple Sclerosis (MS) Drugs Market by Region
  1.4.1 Global Multiple Sclerosis (MS) Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Multiple Sclerosis (MS) Drugs Status and Prospect (2012-2022)
  1.4.3 China Multiple Sclerosis (MS) Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Multiple Sclerosis (MS) Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Multiple Sclerosis (MS) Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Multiple Sclerosis (MS) Drugs Status and Prospect (2012-2022)
  1.4.7 India Multiple Sclerosis (MS) Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Multiple Sclerosis (MS) Drugs (2012-2022)
  1.5.1 Global Multiple Sclerosis (MS) Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Multiple Sclerosis (MS) Drugs Market Competition by Players/Suppliers
  2.1.1 Global Multiple Sclerosis (MS) Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Multiple Sclerosis (MS) Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Multiple Sclerosis (MS) Drugs (Volume and Value) by Type
  2.2.1 Global Multiple Sclerosis (MS) Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Multiple Sclerosis (MS) Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Multiple Sclerosis (MS) Drugs (Volume and Value) by Region
  2.3.1 Global Multiple Sclerosis (MS) Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Multiple Sclerosis (MS) Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Multiple Sclerosis (MS) Drugs (Volume) by Application

3 UNITED STATES MULTIPLE SCLEROSIS (MS) DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Multiple Sclerosis (MS) Drugs Sales and Value (2012-2017)
  3.1.1 United States Multiple Sclerosis (MS) Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Multiple Sclerosis (MS) Drugs Sales Price Trend (2012-2017)
3.2 United States Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Players
3.3 United States Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Type
3.4 United States Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Application

4 CHINA MULTIPLE SCLEROSIS (MS) DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Multiple Sclerosis (MS) Drugs Sales and Value (2012-2017)
  4.1.1 China Multiple Sclerosis (MS) Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Multiple Sclerosis (MS) Drugs Sales Price Trend (2012-2017)
4.2 China Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Players
4.3 China Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Type
4.4 China Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Application

5 EUROPE MULTIPLE SCLEROSIS (MS) DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Multiple Sclerosis (MS) Drugs Sales and Value (2012-2017)
  5.1.1 Europe Multiple Sclerosis (MS) Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Multiple Sclerosis (MS) Drugs Sales Price Trend (2012-2017)
5.2 Europe Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Players
5.3 Europe Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Type
5.4 Europe Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Application

6 JAPAN MULTIPLE SCLEROSIS (MS) DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Multiple Sclerosis (MS) Drugs Sales and Value (2012-2017)
  6.1.1 Japan Multiple Sclerosis (MS) Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Multiple Sclerosis (MS) Drugs Sales Price Trend (2012-2017)
6.2 Japan Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Players
6.3 Japan Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Type
6.4 Japan Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA MULTIPLE SCLEROSIS (MS) DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Multiple Sclerosis (MS) Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Multiple Sclerosis (MS) Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Multiple Sclerosis (MS) Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Application

8 INDIA MULTIPLE SCLEROSIS (MS) DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Multiple Sclerosis (MS) Drugs Sales and Value (2012-2017)
  8.1.1 India Multiple Sclerosis (MS) Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Multiple Sclerosis (MS) Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Multiple Sclerosis (MS) Drugs Sales Price Trend (2012-2017)
8.2 India Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Players
8.3 India Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Type
8.4 India Multiple Sclerosis (MS) Drugs Sales Volume and Market Share by Application

9 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Bayer AG
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Bayer AG Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Bayhill Therapeutics
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Biogen Idec
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Biogen Idec Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Cinnagen
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Cinnagen Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Daiichi Sankyo
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Daiichi Sankyo Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Eli Lilly
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Eli Lilly Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Fast Forward Llc
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Fast Forward Llc Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Antisense Therapeutics
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Antisense Therapeutics Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Apitope
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Apitope Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Five Prime Therapeutics
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Multiple Sclerosis (MS) Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Genmab
9.12 Artielle Immunotherapeutics
9.13 Genzyme
9.14 Glaxosmithkline
9.15 Gw Pharmaceuticals
9.16 Innate Immunotherapeutics

10 MULTIPLE SCLEROSIS (MS) DRUGS MAUFACTURING COST ANALYSIS

10.1 Multiple Sclerosis (MS) Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Multiple Sclerosis (MS) Drugs
10.3 Manufacturing Process Analysis of Multiple Sclerosis (MS) Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Multiple Sclerosis (MS) Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Multiple Sclerosis (MS) Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS MARKET FORECAST (2017-2022)

14.1 Global Multiple Sclerosis (MS) Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Multiple Sclerosis (MS) Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Multiple Sclerosis (MS) Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Multiple Sclerosis (MS) Drugs Price and Trend Forecast (2017-2022)
14.2 Global Multiple Sclerosis (MS) Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Multiple Sclerosis (MS) Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Multiple Sclerosis (MS) Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Multiple Sclerosis (MS) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Multiple Sclerosis (MS) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Multiple Sclerosis (MS) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Multiple Sclerosis (MS) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Multiple Sclerosis (MS) Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Multiple Sclerosis (MS) Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Multiple Sclerosis (MS) Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Multiple Sclerosis (MS) Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Multiple Sclerosis (MS) Drugs Price Forecast by Type (2017-2022)
14.4 Global Multiple Sclerosis (MS) Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Multiple Sclerosis (MS) Drugs
Figure Global Multiple Sclerosis (MS) Drugs Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Copaxone (Glatiramer Acetate, Copolymer 1) Product Picture
Figure Novantrone (Mitoxantrone) Product Picture
Figure Gilenya (Fingolimod, Fty720) Product Picture
Figure Aubagio (Teriflunomide) Product Picture
Figure Tecfidera (Dimethyl Fumarate) Product Picture
Figure Firategrast (Sb683699, T-0047) Product Picture
Figure Siponimod (Baf312) Product Picture
Figure Others Product Picture
Figure Global Multiple Sclerosis (MS) Drugs Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Multiple Sclerosis (MS) Drugs by Application in 2016
Figure RRMS Examples
Table Key Downstream Customer in RRMS
Figure SPMS Examples
Table Key Downstream Customer in SPMS
Figure PPMS Examples
Table Key Downstream Customer in PPMS
Figure PRMS Examples
Table Key Downstream Customer in PRMS
Figure Global Multiple Sclerosis (MS) Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Multiple Sclerosis (MS) Drugs Sales Share by Players/Suppliers
Figure 2017 Multiple Sclerosis (MS) Drugs Sales Share by Players/Suppliers
Figure Global Multiple Sclerosis (MS) Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Multiple Sclerosis (MS) Drugs Revenue Share by Players
Table 2017 Global Multiple Sclerosis (MS) Drugs Revenue Share by Players
Table Global Multiple Sclerosis (MS) Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Multiple Sclerosis (MS) Drugs by Type (2012-2017)
Figure Global Multiple Sclerosis (MS) Drugs Sales Growth Rate by Type (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Multiple Sclerosis (MS) Drugs by Type (2012-2017)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Multiple Sclerosis (MS) Drugs by Region (2012-2017)
Figure Global Multiple Sclerosis (MS) Drugs Sales Growth Rate by Region in 2016
Table Global Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Multiple Sclerosis (MS) Drugs by Region (2012-2017)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Growth Rate by Region in 2016
Table Global Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Multiple Sclerosis (MS) Drugs by Region (2012-2017)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region in 2016
Table Global Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Multiple Sclerosis (MS) Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Multiple Sclerosis (MS) Drugs by Application (2012-2017)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Application (2012-2017)
Figure United States Multiple Sclerosis (MS) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Multiple Sclerosis (MS) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table United States Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players in 2016
Table United States Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table United States Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type in 2016
Table United States Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table United States Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application in 2016
Figure China Multiple Sclerosis (MS) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Multiple Sclerosis (MS) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table China Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table China Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players in 2016
Table China Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table China Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type in 2016
Table China Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table China Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application in 2016
Figure Europe Multiple Sclerosis (MS) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Multiple Sclerosis (MS) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players in 2016
Table Europe Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type in 2016
Table Europe Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application in 2016
Figure Japan Multiple Sclerosis (MS) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Multiple Sclerosis (MS) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players in 2016
Table Japan Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type in 2016
Table Japan Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Multiple Sclerosis (MS) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Multiple Sclerosis (MS) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application in 2016
Figure India Multiple Sclerosis (MS) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Multiple Sclerosis (MS) Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table India Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table India Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Players in 2016
Table India Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table India Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Type in 2016
Table India Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table India Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Multiple Sclerosis (MS) Drugs Sales Volume Market Share by Application in 2016
Table Bayer AG Basic Information List
Table Bayer AG Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Bayer AG Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Bayer AG Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Bayhill Therapeutics Basic Information List
Table Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Biogen Idec Basic Information List
Table Biogen Idec Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Idec Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Biogen Idec Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Biogen Idec Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Cinnagen Basic Information List
Table Cinnagen Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cinnagen Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Cinnagen Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Cinnagen Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Daiichi Sankyo Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Eli Lilly Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Fast Forward Llc Basic Information List
Table Fast Forward Llc Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Fast Forward Llc Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Fast Forward Llc Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Fast Forward Llc Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Antisense Therapeutics Basic Information List
Table Antisense Therapeutics Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Antisense Therapeutics Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Antisense Therapeutics Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Antisense Therapeutics Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Apitope Basic Information List
Table Apitope Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Apitope Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Apitope Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Apitope Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Sales Growth Rate (2012-2017)
Figure Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Sales Global Market Share (2012-2017
Figure Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Revenue Global Market Share (2012-2017)
Table Genmab Basic Information List
Table Artielle Immunotherapeutics Basic Information List
Table Genzyme Basic Information List
Table Glaxosmithkline Basic Information List
Table Gw Pharmaceuticals Basic Information List
Table Innate Immunotherapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Sclerosis (MS) Drugs
Figure Manufacturing Process Analysis of Multiple Sclerosis (MS) Drugs
Figure Multiple Sclerosis (MS) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Multiple Sclerosis (MS) Drugs Major Players in 2016
Table Major Buyers of Multiple Sclerosis (MS) Drugs
Table Distributors/Traders List
Figure Global Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Multiple Sclerosis (MS) Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Multiple Sclerosis (MS) Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Multiple Sclerosis (MS) Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Multiple Sclerosis (MS) Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Multiple Sclerosis (MS) Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Multiple Sclerosis (MS) Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Multiple Sclerosis (MS) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Multiple Sclerosis (MS) Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Multiple Sclerosis (MS) Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Multiple Sclerosis (MS) Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Multiple Sclerosis (MS) Drugs Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Multiple Sclerosis (MS) Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories